Registered Nurse (RN) Respiratory Practice Exam - Prep & Study Guide

Short-acting beta-agonists are the first choice in managing acute bronchospasm due to their quick action in relaxing bronchial smooth muscle. These medications, such as albuterol, act by stimulating beta-2 adrenergic receptors in the lungs, leading to rapid bronchodilation. This characteristic makes them particularly effective during acute episodes of bronchospasm, such as those seen in asthma or chronic obstructive pulmonary disease (COPD) exacerbations.

The speed of onset, typically within minutes, allows for rapid relief of symptoms such as wheezing, shortness of breath, and chest tightness. Their effectiveness in providing immediate relief makes them essential in emergent situations and a standard component of asthma management plans.

In contrast, intravenous corticosteroids, while beneficial in reducing inflammation, do not have immediate bronchodilatory effects and are used for longer-term management or severe exacerbations rather than for rapid relief. Long-acting beta-agonists, though effective for maintenance therapy, are not suitable for acute situations due to their slower onset of action. Leukotriene modifiers also play a role in managing asthma, but they are not utilized for immediate resolution of bronchospasm.